跳至主要内容
临床试验/EUCTR2015-000658-39-SE
EUCTR2015-000658-39-SE进行中(未招募)1 期

Randomized multicenter study of Acupressure combined with personalized antiemetics based on genetic variations (SNPs) in women undergoing neoadjuvant or adjuvant chemotherapy EC / FEC against breast cancer. - AkupresSNP

Region Jönköpings län0 个研究点目标入组 840 人开始时间: 2016年3月1日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
840

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Until 31 Dec 2020: Women with verified breast cancer planed for first neoadjuvant or adjuvant FEC/EC chemotherapy an
  • Age = 18 years
  • Patients with a cancer diagnosis that are planned for potentially emetogenic chemotherapy
  • Knowledge of the Swedish language
  • Informed consent in writing
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 590
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 250

排除标准

  • ? Distant metastases in patients treated in an adjuvant setting
  • ? Previous treatment with chemotherapy
  • ? Unable to understand information about the study
  • Only until 31 Dec 2020: Contra indication against betamethasone

研究者

发起方
Region Jönköpings län

相似试验